Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
Bristol-Myers, AstraZeneca to present 33 abstracts at ADA Scientific Sessions
Yahoo/Fly on the Wall
Fri, 06/14/13 - 10:26 am
diabetes
Bristol-Myers Squibb
AstraZeneca
Diabetes Drugs Under Scrutiny As FDA Considers Another Study
Pharmalot
Wed, 06/12/13 - 12:40 pm
FDA
diabetes
Merck
Januvia
Onglyza
Bristol-Myers Squibb
Byetta
AstraZeneca
Eli Lilly
Novo Nordisk
Victoza
Tradjenta
Boehringer Ingelheim
When It Comes To Biotech, Diversity Is Key
Seeking Alpha
Wed, 06/12/13 - 09:03 am
biotech
Alkermes
Celgene
AstraZeneca
Coronado Biosciences
Dendreon
Incyte
Isis Pharmaceuticals
JNJ
Eli Lilly
Merck
Novavax
Novartis
Pfizer
Sangamo BioSciences
Pharmacyclics
5 Drugs Stocks Dragging The Industry Down
TheStreet.com
Tue, 06/11/13 - 05:00 pm
Forest Labs
AstraZeneca
Sanofi
Eli Lilly
Abbott Laboratories
AstraZeneca - Conducting Major Acquisitions
Seeking Alpha
Tue, 06/11/13 - 03:58 pm
AstraZeneca
M&A
GSK
Novartis
Omthera
Pearl Therapeutics
Pfizer
AstraZeneca to Pay Up to $1.15 Billion for Pearl
Bloomberg
Mon, 06/10/13 - 06:01 am
M&A
Pearl Therapeutics
AstraZeneca
AstraZeneca’s Acquisition of Omthera Pharma Is a Desperate Act
Motley Fool
Sat, 06/8/13 - 05:53 pm
AstraZeneca
Omthera
M&A
Is Big Pharma Learning From Its Late Stage R&D Setbacks?
Forbes
Fri, 06/7/13 - 10:42 am
R&D
Big Pharma
AstraZeneca
Rigel Pharmaceuticals
Isis Pharmaceuticals Earns $6 Million Payment from AstraZeneca
Yahoo
Thu, 06/6/13 - 10:36 am
Isis Pharmaceuticals
AstraZeneca
2 Under-Covered Pharma Stocks With Yields Above 3%
Seeking Alpha
Wed, 06/5/13 - 11:34 am
Eisai
Bristol-Myers Squibb
Eli Lilly
AstraZeneca
Lonza
Bristol-Myers Squibb and AstraZeneca say FDA will speed up review of lipid disorder drug
Yahoo/AP
Wed, 06/5/13 - 10:05 am
FDA
Bristol-Myers Squibb
metreleptin
AstraZeneca
AstraZeneca Won’t Seek Approval for Rigel Arthritis Drug
Bloomberg
Tue, 06/4/13 - 10:25 am
Rigel
rheumatoid arthritis
AstraZeneca
fostamatinib
ASCO '13: Array Drug First to be Effective Against Melanoma of the Eye
The Street
Sat, 06/1/13 - 12:44 pm
Array Biopharma
melanoma
ocular melanoma
selumetinib
AstraZeneca
Olaparib in Patients With BRCA Mutated Platinum-Sensitive Relapsed Serous Ovarian Cancer: New Data Presented at ASCO
Yahoo/BusinessWire
Sat, 06/1/13 - 12:25 pm
olaparib
ovarian cancer
AstraZeneca
The Future Of Omega-3 Based Lipid Management: All Eyes On Amarin
Seeking Alpha
Fri, 05/31/13 - 12:29 pm
Amarin
Vascepa
AstraZeneca
GSK
Neptune Technologies & Bioresources
Doctor’s Doubts Imperil Lucrative Diabetes Drugs
NY Times, NY
Thu, 05/30/13 - 04:51 pm
physicians
diabetes
Bristol-Myers Squibb
Byetta
Merck
AstraZeneca
Januvia
Novo Nordisk
Eli Lilly
Takeda
Boehringer Ingelheim
Diabetes Drug From Bristol and Astra Wins U.K. Panel’s Backing
Bloomberg
Thu, 05/30/13 - 08:56 am
diabetes
Bristol-Myers Squibb
AstraZeneca
UK
Forixga
Amarin slumps as AstraZeneca buys potential rival
Yahoo/AP
Tue, 05/28/13 - 06:16 pm
Amarin
AstraZeneca
M&A
Omthera
5 Drugs Stocks Driving The Industry Higher
TheStreet.com
Tue, 05/28/13 - 06:13 pm
Biogen Idec
Amgen
Valeant Pharmaceuticals
Celgene
Abbott Laboratories
AstraZeneca
Omthera shares up 89% after AstraZeneca deal
Marketwatch
Tue, 05/28/13 - 08:36 am
Omthera
M&A
AstraZeneca
Pages
« first
‹ previous
…
112
113
114
115
116
117
118
119
120
…
next ›
last »